SCHEMBL7937758

SCHEMBL7937758

COCCNC(=O)CN(C(=O)C(=O)c1c[nH]c2cc(OC)ccc12)C1CCCCC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.61
MAPT P10636 5/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
KDM4E B2RXH2 4/20 0.47
HSD17B10 Q99714 2/20 0.47
LMNA P02545 1/20 0.47
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
GAA P10253 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TP53 P04637 1/20 0.43
POLB P06746 1/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 1/20 0.42
ALOX15 P16050 2/20 0.42
TUBB1 Q9H4B7 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7937760 0.88 ALDH1A1 (0.57) ALDH1A1MAPTL3MBTL1KDM4EHSD17B10
SCHEMBL3946896 0.88 ALDH1A1 (0.56) ALDH1A1MAPTL3MBTL1KDM4EHSD17B10
SCHEMBL3265135 0.85 ALDH1A1 (0.67) ALDH1A1MAPTL3MBTL1KDM4EHSD17B10
SCHEMBL3946900 0.82 ALDH1A1 (0.49) ALDH1A1MAPTL3MBTL1KDM4EHSD17B10
SCHEMBL3946894 0.82 MAPT (0.49) ALDH1A1MAPTL3MBTL1KDM4EHSD17B10
SCHEMBL3950431 0.79 MAPT (0.60) ALDH1A1MAPTL3MBTL1KDM4EHSD17B10
SCHEMBL3946586 0.78 ALDH1A1 (0.54) ALDH1A1MAPTL3MBTL1KDM4EHSD17B10
SCHEMBL7946305 0.77 MAPT (0.62) ALDH1A1MAPTL3MBTL1KDM4EHSD17B10
SCHEMBL3950369 0.77 ALDH1A1 (0.55) ALDH1A1MAPTL3MBTL1KDM4EHSD17B10
SCHEMBL4312470 0.76 ALDH1A1 (0.42) ALDH1A1MAPTL3MBTL1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010035032-A1 CALCIUM ION CHANNEL MODULATORS & USES THEREOF LECTUS THERAPEUTICS LIMITED (GB) 2010-04-01 WO disclosed
WO-2009133387-A1 INDOLE- 3 -GLYOXYLAMIDE DERIVATIVES FOR USE AS CALCIUM ION CHANNEL MODULATORS LECTUS THERAPEUTICS LIMITED (GB) 2009-11-05 WO disclosed